GMILogo_Vertical-Gradient.png
Intimate Lingerie Market to hit USD 23 billion by 2032, says Global Market Insights Inc.
September 23, 2024 05:00 ET | Global Market Insights Inc.
Selbyville, Delaware, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Intimate Lingerie Market size is projected to accrue more than USD 23 billion in revenue by 2032. The expansion of e-commerce is...
GMILogo_Vertical-Gradient.png
Residential Micro Inverter Market to hit $6.2 Bn by 2032, Says Global Market Insights Inc.
September 23, 2024 03:00 ET | Global Market Insights Inc.
Selbyville, Delaware,, Sept. 23, 2024 (GLOBE NEWSWIRE) -- The residential micro inverter market is predicted to exceed USD 6.2 billion by 2032, as reported in a research study by Global Market...
GMILogo_Vertical-Gradient.png
Automotive Bushing Market to reach $241.9 Bn by 2032, Says Global Market Insights Inc.
September 23, 2024 02:30 ET | Global Market Insights Inc.
Selbyville, Delaware, Sept. 23, 2024 (GLOBE NEWSWIRE) -- The automotive bushing market valuation is predicted to cross USD 241.9 by 2032, as reported in a research analysis by Global Market...
BGG Logo.jpg
OFIX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Orthofix Medical Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
September 22, 2024 16:00 ET | Bronstein, Gewirtz & Grossman, LLC
NEW YORK, Sept. 22, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been...
BGG Logo.jpg
LFCR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Lifecore Biomedical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
September 22, 2024 16:00 ET | Bronstein, Gewirtz & Grossman, LLC
NEW YORK, Sept. 22, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been...
BGG Logo.jpg
STLA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Stellantis N.V. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
September 22, 2024 16:00 ET | Bronstein, Gewirtz & Grossman, LLC
NEW YORK, Sept. 22, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been...
BGG Logo.jpg
MLYS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Mineralys Therapeutics, Inc. and Encourages Investors to Contact the Firm!
September 22, 2024 16:00 ET | Bronstein, Gewirtz & Grossman, LLC
NEW YORK, Sept. 22, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising-- NEW YORK--(PR NEWSWIRE)--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of...
BGG Logo.jpg
MRNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Moderna, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
September 22, 2024 16:00 ET | Bronstein, Gewirtz & Grossman, LLC
NEW YORK, Sept. 22, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been...
BGG Logo.jpg
SPIR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Spire Global, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
September 22, 2024 16:00 ET | Bronstein, Gewirtz & Grossman, LLC
NEW YORK, Sept. 22, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been...
Logo.png
Graft versus Host Disease Market to Increase at a CAGR of 9.9% During the Study Period (2020–2034) | DelveInsight
September 22, 2024 00:30 ET | DelveInsight Business Research LLP
New York, USA, Sept. 22, 2024 (GLOBE NEWSWIRE) -- Graft versus Host Disease Market to Increase at a CAGR of 9.9% During the Study Period (2020–2034) | DelveInsight  The graft versus host disease...